Emoksipin - instructions for use, analogs, reviews and release forms (eye drops 1%, injections in ampoules for intramuscular and intravenous injections) of a drug for treatment of hemorrhages in adults, children and in pregnancy

In this article, you can read the instructions for using the drug Emoxipine. Comments of visitors of the site - consumers of this medication, as well as opinions of doctors of specialists on the use of emoxipin in their practice are presented. A big request is to actively add their feedback on the drug: the medicine helped or did not help get rid of the disease, which were observed complications and side effects, possibly not declared by the manufacturer in the annotation. Analogs of Emoxipin in the presence of existing structural analogues.Use to treat hemorrhages and circulatory disorders in adults, children, as well as during pregnancy and lactation.

Emoxipine - angioprotector, reduces the permeability of the vascular wall, is an inhibitor of free radical processes, an antihypoxant and an antioxidant.

Reduces blood viscosity and platelet aggregation, increases the content of cyclic nucleotides (cAMP and cGMP) in platelets and brain tissue, has fibrinolytic activity, reduces the permeability of the vascular wall and the risk of developing hemorrhages, contributes to their resorption. Expands coronary vessels, in the acute period of myocardial infarction limits the magnitude of the focus of necrosis, improves the contractility of the heart and the function of its conductive system. With increased blood pressure has an antihypertensive effect. In acute ischemic impairment of cerebral circulation reduces the severity of neurologic symptoms, increases tissue resistance to hypoxia and ischemia.

It has retinoprotective properties, protects the retina from the damaging effect of high-intensity light, promotes resorption of intraocular hemorrhages, improves microcirculation of the eye.

Composition

Methyl ethylpyridinol hydrochloride (emoxipine) + excipients.

Indications

As part of complex therapy:

• the consequences of cerebrovascular accident of ischemic and hemorrhagic nature;
• ITC;
• postoperative period of epi- and subdural hematomas;
• acute myocardial infarction;
• prevention of reperfusion syndrome;
• unstable angina.

Treatment of eye diseases:

• subconjunctival and intraocular hemorrhage;
• angioretinopathy (including diabetic);
• chorioretinal dystrophy (including atherosclerotic origin);
• dystrophic keratitis;
• vascular thrombosis of the retina;
• complications of myopia;
• protection of the cornea (when wearing contact lenses) and the retina of the eye from exposure to high-intensity light (laser and sunburn, with laserocoagulation);
• trauma, inflammation and burn of the cornea;
• cataracts (including prevention in persons older than 40 years);
• surgical interventions on the eyes;
• condition after surgery for glaucoma with detachment of the choroid.

Forms of release

Eye drops 1%.

Solution for intravenous and intramuscular injection (injections in ampoules for injection).

Instructions for use and how to use them

In neurology and cardiology - intravenously drip (dropper) (20-40 cap / min), 20-30 ml of 3% solution (600-900 mg) 1-3 times a day for 5-15 days (pre-diluted in 200 ml of 0.9% NaCl solution or 5% Dextrose solution). The duration of treatment depends on the course of the disease. Subsequently, they switch to the / m administration - 3-5 ml of a 3% solution 2-3 times a day for 10-30 days.

In ophthalmology - subconjunctival or parabulbar, once a day or every other day. Subconjunctival - 0.2-0.5 ml of 1% solution (2-5 mg), parabulbar - 0.5-1 ml of 1% solution (5-1 mg). Duration of treatment - 10-30 days; it is possible to repeat the course 2-3 times a year.

If necessary - retrobulbarno for 0.5-1 ml of 1% solution once a day for 10-15 days.

To protect the retina in lacerocoagulation (including with limiting and destructive coagulation of tumors) - parabulbar or retrobulbno for 0.5-1 ml of 1% solution for 24 hours and 1 hour before coagulation; then in the same doses (0.5 ml of 1% solution) once a day for 2-10 days.

Side effect

• short-term excitement;
• drowsiness;
• increased blood pressure;
• allergic reactions (skin rashes and others);
• pain, burning and itching at the place of use;
• hyperemia;
• sealing of parorbital tissues (resolves itself).

Contraindications

• hypersensitivity;
• pregnancy.

Application in pregnancy and lactation

Contraindicated in pregnancy.

special instructions

Treatment should be carried out under the control of blood pressure and blood coagulability.

Drug Interactions

Pharmaceutically incompatible with other medicines (can not be diluted or used in one syringe with other drugs).

Eye drops should not be mixed with other drugs. If it is necessary to simultaneously apply other eye drops, the drug is instilled last, after the full absorption of the previous drug (not less than 15 minutes).

Analogues of the drug Emoxipine

Structural analogs for the active substance:

• Cardiocipine;
• Methyl ethylpyridinol Eskom;
• Methyl ethylpyridinol hydrochloride;
• Emotion Optics;
• Emoxibel;
• Emoksipina injection 1%.

Similar medicines:

Other medicines: